Suppr超能文献

寿胎丸治疗复发性自然流产的机制——综述

The mechanism of Shoutai Wan in the treatment of recurrent spontaneous abortion - A review.

作者信息

Dang Xue, Feng Yanchen, Zheng Pan, Liu Diyan, Nuerbiye Yusupu, Liao Ziyun, Liu Feixiang, Che Zhiying

机构信息

Traditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, 450046, China.

College of Acupuncture, Moxibustion and Tuina, Henan University of Chinese Medicine, Zhengzhou, 450046, China.

出版信息

Heliyon. 2024 Jun 17;10(12):e33213. doi: 10.1016/j.heliyon.2024.e33213. eCollection 2024 Jun 30.

Abstract

Recurrent spontaneous abortion (RSA) is a prevalent pregnancy complication with a complex and poorly understood pathogenesis. Shoutai Wan (STW), a traditional Chinese medicine formula, is renowned for its kidney tonifying and fetus tranquilizing effects. It is used to treat miscarriages associated with kidney deficiency, hyperemesis gravidarum, and fetal restlessness. Recently, there has been an increase in experimental studies exploring the use of STW for RSA treatment, making progress in understanding its molecular mechanisms and signaling pathways. This review aims to systematically elucidate the mechanisms by which STW enhances cellular antioxidant capacity, attenuates inflammation, and improves the environment for embryo implantation. This involves regulating multiple signaling pathways, including Nuclear factor-erythroid 2-related factor 2/Heme oxygenase-1, JAK kinase 1/Signal transducer and activator of transcription 3, NOD-like receptor pyrin domain-containing protein/Caspase-1/Gasdermin D, Human Leukocyte Antigen G, Mitogen-activated protein kinase, and Serum and glucocorticoid-regulated kinase 1/Epithelial sodium channel. This review provides a theoretical reference for the clinical application and further experimental researches on the treatment of RSA with STW.

摘要

复发性自然流产(RSA)是一种常见的妊娠并发症,其发病机制复杂且尚不清楚。寿胎丸(STW)是一种中药配方,以补肾安胎功效而闻名。它用于治疗与肾虚、妊娠剧吐和胎动不安相关的流产。最近,探索寿胎丸用于RSA治疗的实验研究有所增加,在了解其分子机制和信号通路方面取得了进展。本综述旨在系统阐明寿胎丸增强细胞抗氧化能力、减轻炎症并改善胚胎着床环境的机制。这涉及调节多种信号通路,包括核因子红细胞2相关因子2/血红素加氧酶-1、JAK激酶1/信号转导子和转录激活子3、含NOD样受体吡咯结构域蛋白/Caspase-1/ Gasdermin D、人类白细胞抗原G、丝裂原活化蛋白激酶以及血清和糖皮质激素调节激酶1/上皮钠通道。本综述为寿胎丸治疗RSA的临床应用和进一步的实验研究提供了理论参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d9a/11252737/7542577b9907/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验